Conference Reports for NATAP

HIV Glasgow 2020, 5-8 October Virtual Meeting Back

Tweet

Lenacapavir Resistance Analysis in a Phase 1b Proof-of-Concept Clinical Study       Glasgow 2020 Oct 5-8 virtual Reported by Jules Levin